ENTITY

BioNTech (BNTX US)

30

Analysis

Health Care • Germany

BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.

more

Refresh

Exchange Announcement • 16 Feb 2024 05:10

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 22 Jan 2024 22:14

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 09 Jan 2024 20:01

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 04 Jan 2024 21:02

Notice of proposed sale of securities pursuant to Rule 144 (PDF)

Exchange Announcement • 22 Dec 2023 05:02

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.3

x